InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,480.41
(
0.29%
)
US TECH 100
19,108.36
(
-0.51%
)
Dow Jones
39,537.27
(
0.99%
)
Brent Oil
85.10
(
1.28%
)
Bitcoin
61,164.48
(
-3.16%
)
Post# of 4972746
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

PennyMaster

Send PM Follow Ignore
Followers 2732
Posts 55279
Boards Moderated 4
Alias Born 08/10/2012

PennyMaster

Re: None

Tuesday, 05/03/2022 10:47:36 AM

Tuesday, May 03, 2022 10:47:36 AM

Post# of 4972746
$RXMD Key Financial Highlights for Year Ended December 31, 2021

• Revenue at $38.9 million

- COVID-19 testing revenue of approximately $4.3 million

- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million

• Gross margin increased to 26% in 2021, from 23% in 2020

• EBITDA increased to $167,000 in 2021 from $7,000 in 2020

• Cash balance of $1.4 million as of December 31, 2021

https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Reports-Full-Year-2021-Financial-Results-Highlighted-by-389-Million-in-Revenue?id=349785

Whale Team

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up